SPL

⚡ Flash Summary

Sitara Peroxide Limited (SPL) announced a change in its official website domain from sitaraperoxide.com to sitaraperoxide.com.pk. The company has requested the Pakistan Stock Exchange (PSX) to update the company’s website address on the PSX portal accordingly. This change is a routine update and is unlikely to have a significant impact on the company’s financial performance or operations. The announcement was made on December 4, 2025.

📌 Key Takeaways

• 🌐 Sitara Peroxide Limited is changing its website domain.
• 🖥️ New domain: sitaraperoxide.com.pk.
• 📢 Announcement date: December 4, 2025.
• 🏢 Company has requested PSX to update the website address.
• ℹ️ Old domain: sitaraperoxide.com.
• 🇵🇰 The new domain is specific to Pakistan (.pk).
• 📝 This is a formal request to update information on the PSX portal.
• 👤 Mazhar Ali Khan, Company Secretary, signed the announcement.
• 📍 Company’s registered office is in Karachi.
• 🏭 Plant is located in Faisalabad.
• 📞 Contact numbers for Karachi and Faisalabad offices are provided.
• 📧 Previous website was www.sitaraperoxide.com

🎯 Investment Thesis

The recommendation is to HOLD Sitara Peroxide Limited. This announcement does not provide any new information that would significantly alter the investment thesis. The company’s fundamentals remain unchanged. Therefore, maintain a HOLD rating with no changes to the existing price target or time horizon.

⚡ Flash Summary

SPL announced: EMERGENT BOD MEETING. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SPL made announcement: EMERGENT BOD MEETING
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SPL. Manual verification required.

⚡ Flash Summary

SPL announced: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Reg. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SPL made announcement: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SPL. Manual verification required.

⚡ Flash Summary

On November 24, 2025, Mr. Nadeem Nisar, a substantial shareholder of Sitara Peroxide Limited (SPL), executed a transaction to buy 31,117 shares at a rate of PKR 55.84 per share. The shares were acquired in ‘ready’ market form via CDC certificates. Following this transaction, Mr. Nisar’s cumulative shareholding increased to 6,254,450 shares, representing 11.35% of the company’s total shareholding. This disclosure was made under clause 5.6.1.(d) of the PSX Regulations.

📌 Key Takeaways

• 🗓️ Transaction Date: November 24, 2025
• 👤 Shareholder: Mr. Nadeem Nisar (Substantial Shareholder)
• 💼 Nature of Transaction: Buy
• 📈 Number of Shares Purchased: 31,117
• 💰 Rate per Share: PKR 55.84
• 📝 Form of Share Certificates: CDC
• 📊 Market: Ready
• 🔢 Cumulative Shareholding: 6,254,450 shares
• ⚖️ Percentage Shareholding: 11.35%
• 📜 Regulatory Compliance: Disclosure under clause 5.6.1.(d) of PSX Regulations
• 🏢 Company: Sitara Peroxide Limited (SPL)

🎯 Investment Thesis

Based solely on this announcement, a HOLD recommendation is appropriate. There is no indication of any material positive or negative event. Further analysis of Sitara Peroxide Limited’s financial performance, industry trends, and overall market conditions is necessary to make a well-informed investment decision. A price target cannot be determined based on this single disclosure.

⚡ Flash Summary

SPL announced: Material Information. Basic analysis suggests neutral sentiment. Professional review recommended.

📌 Key Takeaways

• SPL made announcement: Material Information
• Automated analysis: HOLD signal detected
• Signal strength: 5/10
• This is basic analysis – manual review recommended
• Professional CFA analysis unavailable

🎯 Investment Thesis

Basic HOLD indication for SPL. Manual verification required.

⚡ Flash Summary

Sitara Peroxide Limited (SPL) has released an announcement addressing recent unusual movement in the price and volume of its shares. The company explicitly states that it is unaware of any specific reasons or underlying developments that could have triggered these fluctuations. SPL clarifies that there are no significant matters or activities under consideration and attributes the unusual activity to market speculation. This announcement serves as an official response to an inquiry from the Pakistan Stock Exchange (PSX) regarding the observed price volatility.

📌 Key Takeaways

• 📢 SPL addresses unusual share price movement.
• 🤷 Company unaware of any specific reasons for price fluctuations.
• 🗓️ Refers to PSX inquiry PSX-GEN-2059 dated November 21, 2025.
• 🚫 No important matters or development activities under consideration.
• speculative activity by market participants.

🎯 Investment Thesis

Given the company’s statement clarifying the absence of material developments behind the unusual price movement, a HOLD recommendation seems appropriate. The lack of fundamental triggers for the volatility suggests no immediate need to buy or sell. Monitor future announcements and financial performance for a more informed decision. A price target is not available at the time of this review.

⚡ Flash Summary

Tariq Nisar, a substantial shareholder of Sitara Peroxide Limited (SPL), has increased his stake in the company through multiple transactions. Between November 17 and November 20, 2025, Mr. Nisar purchased a total of 1,426,354 shares at prices ranging from PKR 38.35 to PKR 51.04 per share. These transactions have increased his cumulative shareholding from 7.64% to 8.75%. The disclosure was made on November 21, 2025, in compliance with PSX regulations.

📌 Key Takeaways

• 🗓️ Disclosure made on November 21, 2025.
• 👤 Substantial shareholder: Tariq Nisar.
• 📈 Increased shareholding in Sitara Peroxide Limited (SPL).
• ✔️ Compliant with PSX Regulations u/c 5.6.4.
• 💰 First transaction on November 17, 2025: 817,059 shares bought at PKR 38.35.
• 💰 Second transaction on November 18, 2025: 200,000 shares bought at PKR 43.02.
• 💰 Third transaction on November 20, 2025: 409,295 shares bought at PKR 51.04.
• 📊 Cumulative shareholding increased to 4,821,216 shares.
• 💼 Percentage shareholding increased from 7.64% to 8.75%.
• 🏦 Shares held in CDC (Central Depository Company).
• ✔️ Transactions are share purchases (Buy).
• ℹ️ This disclosure is related to director/CEO/executive interest in the company.

🎯 Investment Thesis

Based solely on this disclosure, a HOLD recommendation is appropriate. The increased shareholding by a substantial shareholder is a moderately positive indicator, but further analysis of the company’s financials and market conditions is required before making a BUY or SELL decision. A price target cannot be reasonably established based on this limited information.

⚡ Flash Summary

Tariq Nisar, a substantial shareholder of Sitara Peroxide Limited (SPL), has increased his stake in the company through multiple transactions. Between November 17 and November 20, 2025, Mr. Nisar purchased a total of 1,426,354 shares at prices ranging from PKR 38.35 to PKR 51.04 per share. These transactions have increased his cumulative shareholding from 7.64% to 8.75%. The disclosure was made on November 21, 2025, in compliance with PSX regulations.

📌 Key Takeaways

• 🗓️ Disclosure made on November 21, 2025.
• 👤 Substantial shareholder: Tariq Nisar.
• 📈 Increased shareholding in Sitara Peroxide Limited (SPL).
• ✔️ Compliant with PSX Regulations u/c 5.6.4.
• 💰 First transaction on November 17, 2025: 817,059 shares bought at PKR 38.35.
• 💰 Second transaction on November 18, 2025: 200,000 shares bought at PKR 43.02.
• 💰 Third transaction on November 20, 2025: 409,295 shares bought at PKR 51.04.
• 📊 Cumulative shareholding increased to 4,821,216 shares.
• 💼 Percentage shareholding increased from 7.64% to 8.75%.
• 🏦 Shares held in CDC (Central Depository Company).
• ✔️ Transactions are share purchases (Buy).
• ℹ️ This disclosure is related to director/CEO/executive interest in the company.

🎯 Investment Thesis

Based solely on this disclosure, a HOLD recommendation is appropriate. The increased shareholding by a substantial shareholder is a moderately positive indicator, but further analysis of the company’s financials and market conditions is required before making a BUY or SELL decision. A price target cannot be reasonably established based on this limited information.